# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-180906
Filing Date
2025-08-14
Accepted
2025-08-14 17:11:12
Documents
72
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | eldn-20250630.htm iXBRL | 10-Q | 2944173
2 | EX-31.1 | eldn-ex31_1.htm | EX-31.1 | 16510
3 | EX-31.2 | eldn-ex31_2.htm | EX-31.2 | 16786
4 | EX-32.1 | eldn-ex32_1.htm | EX-32.1 | 11039
5 | EX-32.2 | eldn-ex32_2.htm | EX-32.2 | 11104
| Complete submission text file | 0001193125-25-180906.txt |  | 11702880

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eldn-20250630.xsd | EX-101.SCH | 1302658
75 | EXTRACTED XBRL INSTANCE DOCUMENT | eldn-20250630_htm.xml | XML | 2448633

Mailing Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612
Business Address 19800 MACARTHUR BLVD. SUITE 250 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 251220916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)